Revision in Intimation under Regulation 30 of LODR dated 23rd May 2025 and 09th June 2025 with respect to allotment of Equity Shares on exercise of Employee Stock Options ( ESOPs).
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has revised its earlier disclosure regarding ESOP allotments. The company is withdrawing its 23rd May 2025 intimation about 174 shares, which was filed by mistake. The corrected disclosure confirms that on 9th June 2025, the Board allotted 14,000 shares under the Management ESOP 2018 at Rs. 23.30 per share and 5,000 shares under the ESOP 2008 at Rs. 188.90 per share. The company raised Rs. 3.26 lakh from the Management ESOP and Rs. 9.45 lakh from the ESOP 2008 through these allotments. After this issue, the total issued share capital stands at 20,85,04,899 equity shares of Re. 1 each. No lock-in applies to these newly allotted shares.
This is a routine ESOP exercise disclosure with a minor correction to a prior erroneous filing. The share dilution is negligible (19,000 shares against over 20.85 crore total shares), so there is no meaningful impact on shareholders or the stock price.